Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Radiotherapy Combined With a 6-month LH-RH Agonist and Abiraterone Hormone Therapy Treatment in Biochemically-relapsing Prostate Cancer Following Surgery
Conditions
Interventions
Abiraterone
Locations
5
France
Institut Bergonié
Bordeaux, France
Centre François Baclesse
Caen, France
Centre Georges François Leclerc
Dijon, France
Centre Leon Berard
Lyon, France
Institut de Cancérologie de l'ouest/René Gauducheau
Saint-Herblain, France
Start Date
December 1, 2012
Primary Completion Date
January 7, 2022
Completion Date
January 7, 2022
Last Updated
May 19, 2022
Lead Sponsor
UNICANCER
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions